Loading quotes...
Forecast
The analysts' average price target is €12.44 (+93.17%). The median is €8.02 (+24.53%).
| Buy |
7 |
| Hold |
13 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2024 | YoY |
|---|---|---|
| Revenue | 383.45M | 11.68% |
| Gross profit | 177.76M | 14.48% |
| Net profit | -92.37M | 78.74% |
| EBITDA | -64.13M | 42.24% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €512.73M |
Number of shares | 81.99M |
52-week high/low | €8.61 - €2.74 |
| Dividends | No |
Beta | 2.10 |
P/E ratio | -5.28 |
PEG ratio | 0.04 |
P/B ratio | 1.18 |
P/S ratio | 1.39 |
Company profile
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
| Name | ACCOLADE INC. DL-,0001 |
| CEO | Rajeev Singh |
| Headquarters | Plymouth Meeting,
pa USA |
| Website | |
| Sector | Industrials |
| Industry | Commercial Services & Supplies |
| IPO | 07/01/2020 |
| Employees | 2,400 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | ACCD |
Frankfurt | 4NE1.F |
Düsseldorf | 4NE1.DU |
München | 4NE1.MU |
